Skip to main content
. Author manuscript; available in PMC: 2023 Jan 4.
Published in final edited form as: Biotech Histochem. 2022 Jan 4;97(1):1–10. doi: 10.1080/10520295.2021.2005147

Table 1.

Patient information.

Patient race Histology Stage Age
AA TNBC IIB 42
AA TNBC IIB 56
AA TNBC IIIA 52
AA TNBC IIB 48
AA TNBC IIB 41
AA TNBC IIIA 50
AA TNBC IIB 48
AA TNBC IIB 46
AA TNBC IIIA 43
AA TNBC IIB 50
AA TNBC IIB 49
AA TNBC IIB 41
AA TNBC IIB 55
AA TNBC IIIA 52
AA TNBC IIB 43
EA TNBC IIB 44
EA TNBC IIIA 46
EA TNBC IIB 50
EA TNBC IIIA 51
EA TNBC IIB 40
EA TNBC IIB 58
EA TNBC IIB 50
EA TNBC IIB 43
EA TNBC IIIA 50
EA TNBC IIB 45
EA TNBC IIB 48
EA TNBC IIB 50
EA TNBC IIIA 49
EA TNBC IIB 47
EA TNBC IIIA 45

AA, African American; EA, European American; TBNC, triple negative breast cancer.